Correlation Between CytomX Therapeutics and Fortress Biotech

Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Fortress Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Fortress Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CytomX Therapeutics and Fortress Biotech, you can compare the effects of market volatilities on CytomX Therapeutics and Fortress Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Fortress Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Fortress Biotech.

Diversification Opportunities for CytomX Therapeutics and Fortress Biotech

0.25

Correlation Coefficient

CytomX Therapeutics  Fortress Biotech

Modest diversification

The 3 months correlation between CytomX and Fortress is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Fortress Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Biotech and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Fortress Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Biotech has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Fortress Biotech go up and down completely randomly.

Pair Corralation between CytomX Therapeutics and Fortress Biotech

Given the investment horizon of 90 days CytomX Therapeutics is expected to under-perform the Fortress Biotech. But the stock apears to be less risky and, when comparing its historical volatility, CytomX Therapeutics is 1.3 times less risky than Fortress Biotech. The stock trades about -0.01 of its potential returns per unit of risk. The Fortress Biotech is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  194.00  in Fortress Biotech on September 16, 2024 and sell it today you would earn a total of  0.00  from holding Fortress Biotech or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

CytomX Therapeutics  vs.  Fortress Biotech

CytomX Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CytomX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, CytomX Therapeutics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Fortress Biotech

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Fortress Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent forward indicators, Fortress Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with CytomX Therapeutics and Fortress Biotech

The main advantage of trading using opposite CytomX Therapeutics and Fortress Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Fortress Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will offset losses from the drop in Fortress Biotech's long position.

The idea behind CytomX Therapeutics and Fortress Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.